To Move Medicine Forward

About Mundipharma

Opens Page

Our medicines

Opens Page

Careers

Opens Page

Partnering

Opens Page

Latest News

Mundipharma presents wealth of data for Penthrox®▼(methoxyflurane) at EUSEM Congress, demonstrating superiority compared to standard of care in trauma pain in adults

Oct 15 2019

Opens Page

FOR EUROPEAN MEDICAL AND TRADE MEDIA ONLY

Swissmedic reviewing licence extension for the SGLT2 inhibitor Invokana® (canagliflozin) in fast-track procedure

Oct 10 2019

Opens Page

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin

Sep 03 2019

Opens Page


The Mundipharma global network of
independent associated companies:


.

Supporting patients and communities

As we live longer, providing good quality medical care becomes an increasingly challenging task for the healthcare sector.

Network capabilities

Since our founding by physician entrepreneurs in 1952, the Mundipharma network of independent associated pharmaceutical companies has served the needs of patients and healthcare providers around the globe by providing novel medicines that address unmet medical needs.

Sharing clinical trial information and results

Clinical trial results for studies managed by Mundipharma Research and more information on our disclosure policy are available here.